Insmed Inducement stock option granted to new employees (in shares) remained flat by 0.0% to 130.6K in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 63.8%, from 361.2K to 130.6K. Over 2 years (FY 2023 to FY 2025), Inducement stock option granted to new employees (in shares) shows a downward trend with a -55.8% CAGR.
An increase suggests aggressive hiring or high competition for talent, while a decrease may indicate slower growth or a shift in compensation strategy.
The number of equity-based awards granted specifically as an inducement to new employees joining the organization. This...
Common in high-growth sectors like biopharma and technology; used to benchmark talent acquisition costs.
other_share_based_compensation_arrangement_by_share_base_b0a938| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | 2.7M | 1.4M | 522.5K |
| YoY Change | — | -46.0% | -63.8% |